Skip to main content

Advertisement

SpringerLink
Log in

Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

Use of heparin derivatives in several cancer types revealed that anticoagulant therapies have a beneficiary side effect: delay of tumor progression. Since there are no data on human melanoma, we have analyzed the effect of heparins in preclinical models. Neither unfractionated heparin (UFH), nor its low molecular weight derivative (LMWH) influenced in vitro or in vivo growth of HT168-M1 human melanoma cells. However, heparins significantly inhibited lung colony formation and liver metastasis development in the concentration range of 20–200 IU/kg, whereas recombinant hirudin was ineffective. The antimetastatic effect was due to an early (5–60 min) inhibition of tumor cell arrest in the lung microvasculature. Analysis of the molecular mechanism of the antimetastatic effect of heparins indicated a specific inhibition of tumor cell migration and matrix invasion. The presented experimental data suggest that heparins have specific antimetastatic effect in the case of human melanoma, which is independent from the coagulation cascade.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. GYH Lip BSP Chin AD. Blann (2002) ArticleTitleCancer and the prothrombotic state Lancet Oncol 3 27–34 Occurrence Handle10.1016/S1470-2045(01)00619-2 Occurrence Handle11908507

    Article  PubMed  Google Scholar 

  2. A Letai DJ. Kuter (1999) ArticleTitleCancer. Coagulation and anticoagulation Oncologist 4 443–9 Occurrence Handle10631688

    PubMed  Google Scholar 

  3. D Green RD Hull R Brant et al. (1992) ArticleTitleLower mortality in cancer patients treated with low-molecular-weight versus standard heparin Lancet 339(8807) 1476 Occurrence Handle10.1016/0140-6736(92)92064-M

    Article  Google Scholar 

  4. AYY Lee MN Levine RI Baker et al. (2003) ArticleTitleLow-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 146–53 Occurrence Handle10.1056/NEJMoa025313 Occurrence Handle12853587

    Article  PubMed  Google Scholar 

  5. LR Zacharski WG Henderson FR Rickles et al. (1981) ArticleTitleEffect of warfarin on survival in small cell carcinoma of the lung JAMA 145 831–5 Occurrence Handle10.1001/jama.245.8.831

    Article  Google Scholar 

  6. LP Zacharski WG Henderson FR Rickles et al. (1984) ArticleTitleEffect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate Cancer 53 2046–52 Occurrence Handle6322957

    PubMed  Google Scholar 

  7. AP Chahinian KJ Propert JH Ware et al. (1989) ArticleTitleA randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the cancer and leukemia group B J Clin Oncol 7 993–1002 Occurrence Handle2547030

    PubMed  Google Scholar 

  8. B Lebeau C Chastang J-M Brechot et al. (1994) ArticleTitleSubcutanous heparin treatment increases survival in small cell lung cancer Cancer 74 38–45 Occurrence Handle8004580

    PubMed  Google Scholar 

  9. GF Tempelhoff Particlevon J Harenberg F Niemann et al. (2000) ArticleTitleEffect of low molecular weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: A prospective randomized double-blind trial Int J Oncol 16 815–24 Occurrence Handle10717252

    PubMed  Google Scholar 

  10. S Constantini A Kanner A Friedmann et al. (2001) ArticleTitleSafety of perioperative minidose heparin in patients undergoing brain tumor surgery: a prospective, randomized double-blind study J Neurosurg 94 918–21 Occurrence Handle11409520

    PubMed  Google Scholar 

  11. F Robert E Busby MB Marques et al. (2003) ArticleTitlePhase II study of docetaxel plus enoxaparin in chemotherapy naïve patients with metastatic non-small cell lung cancer: Preliminary results Lung Cancer 42 237–45 Occurrence Handle10.1016/S0169-5002(03)00354-4 Occurrence Handle14568692

    Article  PubMed  Google Scholar 

  12. SS Smorenburg CJF. Noorden Particlevan (2001) ArticleTitleThe complex effects of heparins on cancer progression and metastasis in experimental studies Pharmacol Rev 59 93–105

    Google Scholar 

  13. L Borsig R Wong J Feramisco et al. (2001) ArticleTitleHeparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis Proc Natl Acad Sci USA 98 3352–7 Occurrence Handle10.1073/pnas.061615598 Occurrence Handle11248082

    Article  PubMed  Google Scholar 

  14. L Borsig R Wong RO Hynes et al. (2002) ArticleTitleSynergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci USA 99 2193–8 Occurrence Handle10.1073/pnas.261704098 Occurrence Handle11854515

    Article  PubMed  Google Scholar 

  15. RJ Ludwing B Bochme M Podda et al. (2004) ArticleTitleEndothelial P-selectin as a target of heparin action in experimental melanoma lung metastasis Cancer Res 64 2743–50 Occurrence Handle15087389

    PubMed  Google Scholar 

  16. M Martin M. Clynes (1993) ArticleTitleComparison of 5 microplate colorimetric assays for in vitrocytotoxicity testing and cell proliferation assays Cytotechnology 11 49–58 Occurrence Handle10.1007/BF00749057 Occurrence Handle7763636

    Article  PubMed  Google Scholar 

  17. E Rásó L Mészáros A Albini et al. (2004) ArticleTitleA WT1 expressing metastatic human Kaposi sarcoma xenograft model Pathol Oncol Res 10 22–5 Occurrence Handle15029257

    PubMed  Google Scholar 

  18. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR). Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition). Br J Cancer 1998; 77: 1–10.

    Google Scholar 

  19. A Amirkoshravi SA Mousa M Amaya et al. (2003) ArticleTitleAntimetastatic effect of tinzaparin, a low-molecular-weight heparin J Thromb Haemost 1 1972–6 Occurrence Handle10.1046/j.1538-7836.2003.00341.x Occurrence Handle12941039

    Article  PubMed  Google Scholar 

  20. ML Nierodzik A Plotkin F Kajumo S. Karpatkin (1991) ArticleTitleThrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo J Clin Invest 87 229–36 Occurrence Handle1845869

    PubMed  Google Scholar 

  21. N Esumi D Fan IJ. Fidler (1991) ArticleTitleInhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor Cancer Res 51 4549–56 Occurrence Handle1873799

    PubMed  Google Scholar 

  22. MA Booden LB Eckert CJ Der J. Trejo (2004) ArticleTitlePersistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion Mol Cell Biol 24 1990–9 Occurrence Handle10.1128/MCB.24.5.1990-1999.2004 Occurrence Handle14966279

    Article  PubMed  Google Scholar 

  23. D Darmoul V Gratiuo H Devaud et al. (2003) ArticleTitleAberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells Am J Pathol 162 1503–13 Occurrence Handle12707033

    PubMed  Google Scholar 

  24. C Tellez M McCarty M Ruiz H. Bar-Eli (2003) ArticleTitleLoss activator protein-2alpha results in overexpression of protease-activated receptor-1 and correlates with the malignant phenotype of human melanoma J Biol Chem 178 46632–42 Occurrence Handle10.1074/jbc.M309159200

    Article  Google Scholar 

  25. M Hejna M Radere CC. Zielinski (1999) ArticleTitleInhibition of metastases by anticoagulants J Natl Cancer Inst 91 22–36 Occurrence Handle10.1093/jnci/91.1.22 Occurrence Handle9890167

    Article  PubMed  Google Scholar 

  26. A Koenig K Norgard-Sumnicht R Linhardt et al. (1998) ArticleTitleDifferential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins J Clin Invest 101 877–89 Occurrence Handle9466983

    PubMed  Google Scholar 

  27. L Wang JR Brown A Varki et al. (2002) ArticleTitleHeparin’s anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins J Clin Invest 110 127–36 Occurrence Handle10.1172/JCI200214996 Occurrence Handle12093896

    Article  PubMed  Google Scholar 

  28. R Sasisekharan Z Shriver G Venkataraman et al. (2002) ArticleTitleRoles of heparan-sulphate glycosaminoglycans in cancer Nat Rev Cancer 2 521–8 Occurrence Handle10.1038/nrc842 Occurrence Handle12094238

    Article  PubMed  Google Scholar 

  29. A-Q Ma J-G. Geng (2000) ArticleTitleHeparan sulfate-like proteoglycans mediate adhesion of human malignant melanoma A375 cells to P-selectin under flow J Immunol 165 558–65 Occurrence Handle10861096

    PubMed  Google Scholar 

  30. B Döme B Somlai A Ladányi et al. (2001) ArticleTitleExpression of CD44v3 splice variant is associated with the visceral metastatic phenotype of human melanoma Virchows Arch 439 628–35 Occurrence Handle11764382

    PubMed  Google Scholar 

  31. J Tímár K Lapis J Dudás et al. (2002) ArticleTitleProteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer Sem Cancer Biol 12 173–86 Occurrence Handle10.1016/S1044-579X(02)00021-4

    Article  Google Scholar 

  32. J Tímár CS Diczházi I Bartha et al. (1995) ArticleTitleModulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells Int J Cancer 62 755–61 Occurrence Handle7558426

    PubMed  Google Scholar 

  33. K Fazekas E Rásó M Zarándi et al. (2002) ArticleTitleBasic HGF-like peptides inhibit generation of liver metastases in murine and human tumor models Anticancer Res 22 2575–80 Occurrence Handle12529966

    PubMed  Google Scholar 

  34. MS Da Silva JA Horton JM Wijelath et al. (2003) ArticleTitleHeparin modulates integrin-mediated cellular adhesion: Specificity of interactions with alpha and beta integrin subunits Cell Commun Adhes 10 59–67 Occurrence Handle14681057

    PubMed  Google Scholar 

  35. M Trikha J Tímár A Zacharek et al. (2002) ArticleTitleRole for β3 integrins in human melanoma growth and survival Int J Cancer 101 156–67 Occurrence Handle10.1002/ijc.10521 Occurrence Handle12209993

    Article  PubMed  Google Scholar 

  36. M Trikha Z Zhou J Tímár et al. (2002) ArticleTitleMultiple roles for platelet gpIIb/IIIa and αvβ3 integrins in tumor growth, angiogenesis and metastasis Cancer Res 62 2824–833 Occurrence Handle12019160

    PubMed  Google Scholar 

  37. P Friedl K. Wolf (2003) ArticleTitleCell–cell invasion and migration: Diversity and escape mechanisms Nat Rev Cancer 3 362–74 Occurrence Handle10.1038/nrc1075 Occurrence Handle12724734

    Article  PubMed  Google Scholar 

  38. K Wolf R Müller S Borgmann et al. (2003) ArticleTitleAmoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases Blood 102 3262–9 Occurrence Handle10.1182/blood-2002-12-3791 Occurrence Handle12855577

    Article  PubMed  Google Scholar 

  39. P Thodiyil AK. Kakkar (2002) ArticleTitleCan low-molecular-weight heparins improve outcome in patients with cancer? Cancer Treat Rev 28 151–5 Occurrence Handle10.1016/S0305-7372(02)00040-3 Occurrence Handle12234567

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Tumor Progression, National Institute of Oncology, Budapest, Hungary

    Bíborka Bereczky, Réka Gilly, Erzsébet Rásó, József Tímár & József Tóvári

  2. Central Laboratory, National Institute of Oncology, Ráth Gy. u. 7-9, 1122, Budapest, Hungary

    Ágnes Vágó

Authors
  1. Bíborka Bereczky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Réka Gilly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erzsébet Rásó
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ágnes Vágó
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. József Tímár
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. József Tóvári
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to József Tímár.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bereczky, B., Gilly, R., Rásó, E. et al. Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest. Clin Exp Metastasis 22, 69–76 (2005). https://doi.org/10.1007/s10585-005-3859-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10585-005-3859-6

Keywords

Search

Navigation